These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 8729519)

  • 21. Somatic trinucleotide change encompassing codons 882 and 883 of the RET proto-oncogene in a patient with sporadic medullary thyroid carcinoma.
    Bugalho MJ; Coelho I; Sobrinho LG
    Eur J Endocrinol; 2000 Jun; 142(6):573-5. PubMed ID: 10822219
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma.
    Hofstra RM; Landsvater RM; Ceccherini I; Stulp RP; Stelwagen T; Luo Y; Pasini B; Höppener JW; van Amstel HK; Romeo G
    Nature; 1994 Jan; 367(6461):375-6. PubMed ID: 7906866
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel point mutation in the tyrosine kinase domain of the RET proto-oncogene in sporadic medullary thyroid carcinoma and in a family with FMTC.
    Eng C; Smith DP; Mulligan LM; Healey CS; Zvelebil MJ; Stonehouse TJ; Ponder MA; Jackson CE; Waterfield MD; Ponder BA
    Oncogene; 1995 Feb; 10(3):509-13. PubMed ID: 7845675
    [TBL] [Abstract][Full Text] [Related]  

  • 24. RET proto-oncogene point mutations in sporadic neuroendocrine tumors.
    Komminoth P; Roth J; Muletta-Feurer S; Saremaslani P; Seelentag WK; Heitz PU
    J Clin Endocrinol Metab; 1996 Jun; 81(6):2041-6. PubMed ID: 8964826
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Proto-oncogene RET somatic mutations in medullary thyroid carcinoma].
    Wiench M; Kwaśniewski M; Gubała E; Wygoda Z; Pawlaczek A; Oczko M; Jarzab B
    Wiad Lek; 2001; 54 Suppl 1():415-21. PubMed ID: 12182058
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutations in the cysteine-rich region of the RET proto-oncogene in patients diagnosed as having sporadic medullary thyroid carcinoma.
    Kimura T; Yoshimoto K; Yokogoshi Y; Saito S
    Endocr J; 1995 Aug; 42(4):517-25. PubMed ID: 8556059
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Point mutation within the tyrosine kinase domain of the RET proto-oncogene in multiple endocrine neoplasia type 2B and related sporadic tumours.
    Eng C; Smith DP; Mulligan LM; Nagai MA; Healey CS; Ponder MA; Gardner E; Scheumann GF; Jackson CE; Tunnacliffe A
    Hum Mol Genet; 1994 Feb; 3(2):237-41. PubMed ID: 7911697
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 27-bp deletion in the ret proto-oncogene as a somatic mutation associated with medullary thyroid carcinoma.
    Kalinin V; Frilling A
    J Mol Med (Berl); 1998 Apr; 76(5):365-7. PubMed ID: 9587071
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A complex nine base pair deletion in RET exon 11 common in sporadic medullary thyroid carcinoma.
    Alemi M; Lucas SD; Sällström JF; Bergholm U; Akerström G; Wilander E
    Oncogene; 1997 May; 14(17):2041-5. PubMed ID: 9160884
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Familial medullary thyroid carcinoma with noncysteine ret mutations: phenotype-genotype relationship in a large series of patients.
    Niccoli-Sire P; Murat A; Rohmer V; Franc S; Chabrier G; Baldet L; Maes B; Savagner F; Giraud S; Bezieau S; Kottler ML; Morange S; Conte-Devolx B;
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3746-53. PubMed ID: 11502806
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A codon 891 exon 15 RET proto-oncogene mutation in familial medullary thyroid carcinoma: a detection strategy.
    Dang GT; Cote GJ; Schultz PN; Khorana S; Decker RA; Gagel RF
    Mol Cell Probes; 1999 Feb; 13(1):77-9. PubMed ID: 10024437
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel somatic mutation in the RET proto-oncogene in familial medullary thyroid carcinoma with a germline codon 768 mutation.
    Miyauchi A; Egawa S; Futami H; Kuma K; Obara T; Yamaguchi K
    Jpn J Cancer Res; 1997 Jun; 88(6):527-31. PubMed ID: 9263528
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutation of the RET proto-oncogene is correlated with RET immunostaining in subpopulations of cells in sporadic medullary thyroid carcinoma.
    Eng C; Thomas GA; Neuberg DS; Mulligan LM; Healey CS; Houghton C; Frilling A; Raue F; Williams ED; Ponder BA
    J Clin Endocrinol Metab; 1998 Dec; 83(12):4310-3. PubMed ID: 9851769
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic value of codon 918 (ATG-->ACG) RET proto-oncogene mutations in sporadic medullary thyroid carcinoma.
    Schilling T; Bürck J; Sinn HP; Clemens A; Otto HF; Höppner W; Herfarth C; Ziegler R; Schwab M; Raue F
    Int J Cancer; 2001 Jan; 95(1):62-6. PubMed ID: 11241313
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relevance of RET proto-oncogene mutations in sporadic medullary thyroid carcinoma.
    Wohllk N; Cote GJ; Bugalho MM; Ordonez N; Evans DB; Goepfert H; Khorana S; Schultz P; Richards CS; Gagel RF
    J Clin Endocrinol Metab; 1996 Oct; 81(10):3740-5. PubMed ID: 8855832
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Somatic ret proto-oncogene mutations in sporadic C-cell carcinoma of the thyroid gland].
    Frilling A; Bockhorn M; Kalinin V; Liedke M; Kaun M; Broelsch CE
    Chirurg; 1997 Aug; 68(8):789-93. PubMed ID: 9377989
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutation analysis of the RET proto-oncogene in Dutch families with MEN 2A, MEN 2B and FMTC: two novel mutations and one de novo mutation for MEN 2A.
    Landsvater RM; Jansen RP; Hofstra RM; Buys CH; Lips CJ; Ploos van Amstel HK
    Hum Genet; 1996 Jan; 97(1):11-4. PubMed ID: 8557249
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A new hot spot for mutations in the ret protooncogene causing familial medullary thyroid carcinoma and multiple endocrine neoplasia type 2A.
    Berndt I; Reuter M; Saller B; Frank-Raue K; Groth P; Grussendorf M; Raue F; Ritter MM; Höppner W
    J Clin Endocrinol Metab; 1998 Mar; 83(3):770-4. PubMed ID: 9506724
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Very early detection of RET proto-oncogene mutation is crucial for preventive thyroidectomy in multiple endocrine neoplasia type 2 children: presence of C-cell malignant disease in asymptomatic carriers.
    Sanso GE; Domene HM; Garcia R; Pusiol E; de M; Roque M; Ring A; Perinetti H; Elsner B; Iorcansky S; Barontini M
    Cancer; 2002 Jan; 94(2):323-30. PubMed ID: 11900218
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Large-scale analysis of mutations in RET exon 16 in sporadic medullary thyroid carcinomas in Japan.
    Takano T; Miyauchi A; Yoshida H; Hasegawa Y; Kuma K; Amino N
    Jpn J Cancer Res; 2001 Jun; 92(6):645-8. PubMed ID: 11429053
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.